Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Aino Fianu‐Jonasson"'
Publikováno v:
Advances in Urology, Vol 2021 (2021)
A multicenter, randomized, controlled clinical trial and four postmarket user acceptance investigations were carried out to document the safety, performance, and user acceptance of Efemia Bladder Support, a novel vaginal inlay for the temporary reduc
Externí odkaz:
https://doaj.org/article/3c3b2fc076e44683a09192790623f2a7
Autor:
Ulrike Schimpf, Erika Caldas-Silveira, Ljudmila Katchan, Cécile Vigier-Carriere, Isabelle Lantier, Gilai Nachmann, Sebastian Gidlöf, Aino Fianu Jonasson, Lars Björndahl, Stéphane Trombotto, Xavier Druart, Thomas Crouzier
Publikováno v:
Science translational medicine. 14(673)
Close to half of the world's pregnancies are still unplanned, reflecting a clear unmet need in contraception. Ideally, a contraceptive would provide the high efficacy of hormonal treatments, without the systemic side effects of hormones. Here we prop
Publikováno v:
Medical Devices: Evidence and Research. 13:339-347
Purpose The primary objective was to compare the efficacy of 12 weeks of daily treatment with Aqueous Hypromellose-based vaginal (Vagivital®) gel versus Aqueous Hypromellose-based vaginal gel plus 400 IU oxytocin gel in reducing the severity of the
Autor:
Aino Fianu Jonasson, Ylva Crona Guterstam, Sebastian Gidlöf, Niklas K. Björkström, Anna-Sofia Melin, Benedikt Strunz, Martin A. Ivarsson, Christine L. Zimmer
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica
Introduction The menstrual cycle is regulated by a complex interplay between endometrial epithelial cells, endothelial cells, immune cells, and sex hormones. To communicate, cells secrete cytokines that have multiple and diverse effects on recipient
Autor:
Mikael Åstrom, Aino Fianu Jonasson
Publikováno v:
Medical Devices (Auckland, N.Z.)
Aino Fianu Jonasson,1 Mikael Ã
strom2 1Department of Clinical Sciences, Intervention, and Technology, Division of Obstetrics and Gynaecology, Karolinska Institute, Stockholm, Sweden; 2StatCons, Malmö, SwedenCorrespondence: Aino Fianu JonassonDep
Autor:
Linus Olausson, Simon Olofsson, Bo Jacobsson, Jean-Marc Costa, Olof Karlberg, Eva Åström, Kypros H. Nicolaides, Åsa Janfalk-Carlsson, Björn Andersson, Olle Ericsson, Atefeh Mohsenchian, Björn Skarpås, Faizan Hakamali, Tarja Ahola, Anna Sahlberg, Aino Fianu-Jonasson, Johanna Lundgren, Filip Karlsson, Fredrik Dahl, Ida Alftrén, Atif Qureshi, Niels Francois, Per-Ola Forsgren, Jenny Dahlberg, Anna Gousseva, Emelie Barkenäs, Fredrik Roos, Anna Sävneby, Fredrik Persson, Birgit Brandner, Henrik Johansson, Ani Boghos, Jérémie Gautier, Peter Svahn
Publikováno v:
Prenatal Diagnosis
Objective To evaluate clinical performance of a new automated cell‐free (cf)DNA assay in maternal plasma screening for trisomies 21, 18, and 13, and to determine fetal sex. Method Maternal plasma samples from 1200 singleton pregnancies were analyze
Publikováno v:
Advances in Urology, Vol 2021 (2021)
Advances in Urology
Advances in Urology
A multicenter, randomized, controlled clinical trial and four postmarket user acceptance investigations were carried out to document the safety, performance, and user acceptance of Efemia Bladder Support, a novel vaginal inlay for the temporary reduc
Publikováno v:
Medical Devices (Auckland, N.Z.)
Purpose The primary objective was to compare the efficacy of 12 weeks of daily treatment with Aqueous Hypromellose-based vaginal (Vagivital®) gel versus Aqueous Hypromellose-based vaginal gel plus 400 IU oxytocin gel in reducing the severity of the
Autor:
Olof Hertting, Åsa Holm, Petra Lüthje, Hanna Brauner, Robert Dyrdak, Aino Fianu Jonasson, Peter Wiklund, Milan Chromek, Annelie Brauner
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15580 (2010)
The urinary tract is frequently being exposed to potential pathogens and rapid defence mechanisms are therefore needed. Cathelicidin, a human antimicrobial peptide is expressed and secreted by bladder epithelial cells and protects the urinary tract f
Externí odkaz:
https://doaj.org/article/856a291ea229476eb151546c91edfe47
Publikováno v:
The Journal of Clinical Pharmacology. 57:1573-1581
Oxytocin is a neuropeptide hormone used clinically for more than 50 years due to its ability to induce uterine contractions and milk ejection. Vagitocin is a vaginal oxytocin gel developed as a potential treatment of vaginal atrophy in postmenopausal